Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1024329

O=C(O)C(F)(F)F.O=C(O)CC1CCN(c2ccccn2)CC1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
KDM4E B2RXH2 3/20 0.55
HSD17B10 Q99714 2/20 0.55
FFAR4 Q5NUL3 2/20 0.54
DPP4 P27487 1/20 0.53
DPP8 Q6V1X1 1/20 0.53
DPP9 Q86TI2 1/20 0.53
DPP7 Q9UHL4 1/20 0.53
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
RECQL P46063 1/20 0.50
FFAR1 O14842 1/20 0.49
GPR119 Q8TDV5 1/20 0.47
DRD2 P14416 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
HTR1A P08908 1/20 0.45
RIPK1 Q13546 1/20 0.45
AVPR1A P37288 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13622621 0.92 ALDH1A1 (0.62) ALDH1A1KDM4EHSD17B10CYP3A4CYP2C9
SCHEMBL1025882 0.84 KDM4E (0.53) ALDH1A1KDM4EHSD17B10DPP4DPP8
Trifluoroacetic Acid SCHEMBL1024081 0.84 KDM4E (0.54) ALDH1A1KDM4EFFAR4DPP4DPP8
Trifluoroacetic Acid SCHEMBL3904463 0.83 DPP4 (0.61) ALDH1A1KDM4EHSD17B10DPP4DPP8
Trifluoroacetic Acid SCHEMBL1023388 0.82 DPP4 (0.53) ALDH1A1KDM4EFFAR4DPP4DPP8
SCHEMBL19134108 0.82 FFAR4 (0.65) ALDH1A1KDM4EHSD17B10FFAR4CYP3A4
Trifluoroacetic Acid SCHEMBL1026170 0.82 FFAR4 (0.59) FFAR4CYP3A4
SCHEMBL1024330 0.82 ALDH1A1 (0.52) ALDH1A1KDM4EHSD17B10DPP4DPP8
Trifluoroacetic Acid SCHEMBL1025547 0.81 FFAR1 (0.50) FFAR4DPP4DPP9DPP7FFAR1
Trifluoroacetic Acid SCHEMBL1024921 0.81 FFAR4 (0.56) FFAR4DPP4DPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871753-B2 Macrocyclic compounds and their use as kinase inhibitors INCYTE CORPORATION (US) 2014-10-28 US disclosed
EP-2274288-A2 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS Incyte Corporation (US) 2011-01-19 EP disclosed
US-20090286778-A1 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-11-19 US disclosed
WO-2009132202-A2 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286778-A1 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS JAK2, JAK1, ALK ALDH1A1 2511/4885KDM4E 248/4885HSD17B10 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.